DNAverse, the world’s first art NFT collection customized with real DNA data, has announced today a strategic partnership with Polygon Studios, an organization onboarding developer, brands, artists, and content creators to Web3 through investment, marketing, developer, and community support.
DNAverse and Polygon Studios will collaborate to spearhead the development of the BIOmetaverse on the Polygon blockchain.
DNAverse is the first project in the world to artistically interpret users’ real DNA and create a 3D model NFT artwork. The collection, comprised of 3,200 NFTs, is one-to-one handcrafted and includes a personalized visualization of collectors’ own genetics, presented as DNArts, which grant holders access to a utility business model of life replication on the metaverse, ushering in the BIOmetaverse concept.
The mission of DNAverse is to greatly enhance social interactions in the metaverse by enabling the total customization of NFT collections and Avatars (BIOavatars).
In addition, the platform aims to bring much-needed human verification to the metaverse (as opposed to KYC or Biometrics) to ensure humans can be easily distinguished from increasingly prevalent chatbots and AI.
All DNAverse users’ genetic information is securely handled by a licensed DNA laboratory and remains fully anonymous. No data is collected, stored, or shared by DNAverse at any stage in the process and users control their data at all times. As an exclusive benefit for DNAverse collectors, the codification of the genetic information on the blockchain will be offered as an optional feature.
The platform will be launching a landmark collection inspired by the essential proteins to life, consisting of 200 genesis Cryptoproteins and 3,000 DNA passes. Cryptoproteins are 3D assets meticulously designed one by one by 3DforScience, with complete scientific accuracy, endorsed by the Protein Data Bank – an internationally recognized scientific organization.
Holders of cryptoproteins will also receive a DNArt NFT with genotype 0, becoming the ancestors of human life in the metaverse, and the rulers of DNAverse’s bespoke Replication Process (Breeding lab).
Following the cryptoprotein genesis drop, DNAverse will hold the main drop-in which a total of 3,000 DNA Passes will be made available in the only centralized drop of DNA NFTs. At this point, the replication process becomes decentralized and rapidly scalable across multiverses and cross-chain.
Javier M. Floren, CEO & Co-founder of DNAverse said: “Our strategic partnership with Polygon gives expression to our ambitions to expedite the development of the BIOmetaverse. With rapid speed and low transaction fees, Polygon has underlined its credentials as one of the world’s preeminent and scalable blockchain ecosystems. We are firmly aligned with Polygon’s mission to prioritize security and system reliability while facilitating high levels of developer engagement. This is yet another firm seal of approval for the unique DNAverse offering, and will help us extend our value proposition to new swathes of crypto and NFT enthusiasts.”
Steven Bryson-Haynes, VP of Business Development, NFT & Gaming at Polygon Studios, said: “The vision of the BioMetaverse being created by DNAverse gives users innovative and personal customization of their metaverse avatars while natively solving the problem of human verification. Together with the DNAverse team, we have the opportunity to redefine the metaverse concept in a manner that is completely privacy-centric and scientifically authentic, delivering uniquely individualized NFTs that have genuine utility.”
